Skip to main content
Log in

Novel tool for tacrolimus monitoring promising, feasible, no cost saving

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by an unrestricted grant from Astellas Pharma Ltd.

Reference

  • Veenhof H, et al. Effects, costs and implementation of monitoring kidney transplant patients' tacrolimus levels with Dried Blood Spot sampling: a randomized controlled hybrid implementation trial. British Journal of Clinical Pharmacology : 19 Feb 2020

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Novel tool for tacrolimus monitoring promising, feasible, no cost saving. PharmacoEcon Outcomes News 848, 16 (2020). https://doi.org/10.1007/s40274-020-6629-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6629-4

Navigation